<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "http://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial" dtd-version="1.1" specific-use="sps-1.9" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">ijcs</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Cardiovascular Sciences</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Int. J. Cardiovasc. Sci.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2359-4802</issn>
      <issn pub-type="epub">2359-5647</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id specific-use="scielo-v3" pub-id-type="publisher-id">Vn8MZQ6JVRQBJXsTstMnFtH</article-id>
      <article-id specific-use="scielo-v2" pub-id-type="publisher-id">S2359-56472021000600066</article-id>
      <article-id pub-id-type="publisher-id">ijcs.20210245</article-id>
      <article-id pub-id-type="doi">10.36660/ijcs.20210245</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Editorial</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>TG/HDL-c Ratio as a Predictor of Cardiovascular Risk</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <contrib-id contrib-id-type="orcid">0000-0001-7235-9467</contrib-id>
          <name>
            <surname>Aranha</surname>
            <given-names>Luciana Nicolau</given-names>
          </name>
          <xref ref-type="corresp" rid="c1"/>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <aff id="aff1">
          <institution content-type="orgname">Universidade Federal do Rio de Janeiro</institution>
          <addr-line>
            <named-content content-type="city">Rio de Janeiro</named-content>
            <named-content content-type="state">RJ</named-content>
          </addr-line>
          <country country="BR">Brazil</country>
          <institution content-type="original">Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ - Brazil</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1"><bold>Mailing Address: Luciana Nicolau Aranha</bold>, Hospital Universit&#225;rio Clementino Fraga Filho &#8211; UFRJ Rua Prof. Rodolpho P. Rocco, 255, 8&#176; andar, sala 6. Postal Code: <postal-code>21941-901</postal-code>, Cidade Universit&#225;ria, Rio de Janeiro, RJ &#8211; Brazil. E-mail: <email>luciana_nicolau@hotmail.com</email> </corresp>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>01</day>
        <month>11</month>
        <year>2021</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2021</year>
      </pub-date>
      <volume>34</volume>
      <issue>5 Supl 1</issue>
      <fpage>66</fpage>
      <lpage>67</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Cardiovascular Disease</kwd>
        <kwd>Risk Fators</kwd>
        <kwd>Dyslipidemias</kwd>
        <kwd>Hypertension</kwd>
        <kwd>Diabetes Mellitus</kwd>
      </kwd-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="14"/>
        <page-count count="2"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <p>Cardiovascular diseases (CVD) continue to be an important public health problem and one of the main causes of morbidity and mortality worldwide, generating economic and social impacts.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref>,<xref ref-type="bibr" rid="B2"><sup>2</sup></xref> In Brazil, CVD costs have been increasing significantly and are the highest when compared to other causes of hospitalization. Moreover, as the population ages, and with the increase in CVD prevalence, these expenses tend to be even higher.<xref ref-type="bibr" rid="B3"><sup>3</sup></xref> Therefore, early detection and possible changes in cardiovascular risk factors can be important in order to reduce hospitalization and negative outcomes, as well as to improve the population's quality of life.</p>
    <p>In an attempt to identify asymptomatic individuals with a greater predisposition for the disease and define therapeutic goals, many evaluation tools have been developed to estimate risks for CVD, such as Framingham's Global Risk Score (GRS), adopted by the Department of Atherosclerosis of the Brazilian Society of Cardiology (SBC-DA, in Portuguese) and which evaluates the risk of cardiovascular events over a 10-year period through the variables of age, sex, high-density lipoprotein cholesterol (HDL-c), total cholesterol, systolic blood pressure, smoking, and diabetes.<xref ref-type="bibr" rid="B4"><sup>4</sup></xref> </p>
    <p>Based in this premise, other indexes have been proposed to predict the cardiovascular risk, among which, what stands out are the ratio between triglycerides (TG) and HDL-c (TG/HDL-c), which reflects small and dense particles of low-density lipoprotein (LDL), which are more atherogenic than the larger floating LDL particles.<xref ref-type="bibr" rid="B5"><sup>5</sup></xref>,<xref ref-type="bibr" rid="B6"><sup>6</sup></xref> The TG/HDL ratio has proven to be a good predictor for myocardial infarction<xref ref-type="bibr" rid="B7"><sup>7</sup></xref>,<xref ref-type="bibr" rid="B8"><sup>8</sup></xref>, and was associated with the incidence of cardiovascular diseases, type 2 diabetes mellitus, and metabolic syndrome.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref> In addition, it was reported that a high TG/HDL-c relationship is significantly associated with an increase in the resistance to insulin in apparently healthy individuals, thus suggesting that this measure can serve as a simple and clinically useful method to identify apparently healthy young individuals who are resistant to insulin and who present an increased cardiometabolic risk.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref> </p>
    <p>In the current edition of the <italic>International Journal of Cardiovascular Sciences</italic>, Silva et al.,<xref ref-type="bibr" rid="B11"><sup>11</sup></xref> evaluated 833 individuals, of whom 62.8% were women, with an average age of 62 years, with high blood pressure and/or diabetes, who received medical care at the Family Health Unit in the city of Vi&#231;osa, Minas Gerais, Brazil. Exams showed that the cut-off values of the TG/HDL-c ratio that reflect a cardiovascular risk were &#8805; 3.26 for men and &#8805; 2.72 for women. Moreover, for women with multiple risks, the chance of an alteration in the TG/HDL-c ratio increased by 90%.</p>
    <p>The cut-off values considered by Silva et al.,<xref ref-type="bibr" rid="B11"><sup>11</sup></xref> were different from those observed in other populations, such as in Argentina (&gt;3.5 in men; &gt;2.5 in women)<xref ref-type="bibr" rid="B12"><sup>12</sup></xref>, Iran (&gt;4.42 for men; 3.76 for women, and 3.68 for both sexes)<xref ref-type="bibr" rid="B13"><sup>13</sup></xref>, and Spain (&gt;2.75 for men and &gt; 1.65 for women).<xref ref-type="bibr" rid="B14"><sup>14</sup></xref> Wakabayashi e Daimon<xref ref-type="bibr" rid="B5"><sup>5</sup></xref> compared the discrimination for cardiovascular risk for different cut-off values of the TG/HDL-c relationship and observed that the optimum cut-off value was of 2.967 in men and 2.237 in women. As observed, the values are diverse among the population, which can possibly be explained by genetic factors, the geographic region, race/ethnicity, and the age of the individuals.</p>
    <p>In Brazil, studies that evaluate the cut-off values of the TG/HDL-c ratio are scarce, which hinders the comparison with the results obtained by Silva et al.,<xref ref-type="bibr" rid="B11"><sup>11</sup></xref> and show the importance of this investigation for scientific literature. However, the results cannot be extrapolated to the Brazilian population in general, since the results were obtained in a specific population in the state of Minas Gerais. Brazil has a high degree of miscegenation and the TG/HDL-c ratio can be influenced by ethnicity; therefore, representative samples of each region should be used so that the results can be more broadly generalized.</p>
    <p>In conclusion, the TG/HDL-c ratio is an easy, accessible, and economical measure that can be useful in predicting the cardiovascular risk in routine exams and triage in Primary Health Care. Nevertheless, more studies are warranted in order to establish the optimum cut-off point. Studies should also include confounding factors, such as socioeconomic status, food consumption, and physical activity.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="other" id="fn1">
        <p>Referent to the article: Optimal Cutoff of the TG/HDL-c ratio for Cardiovascular Risk in Hypertensive and Diabetic Patients Monitored by Primary Health Care in a city in Minas Gerais</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roth</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Mensah</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>CO</given-names>
            </name>
            <name>
              <surname>Addolorato</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ammirati</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Baddour</surname>
              <given-names>LM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2020</year>
          <month>12</month>
          <day>22</day>
          <volume>76</volume>
          <issue>25</issue>
          <fpage>2982</fpage>
          <lpage>3021</lpage>
          <pub-id pub-id-type="doi">10.1016/j.acc.220.11.010</pub-id>
        </element-citation>
        <mixed-citation>1 Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. Doi:10.1016/j.acc.220.11.010.</mixed-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>GMM</given-names>
            </name>
            <name>
              <surname>Brant</surname>
              <given-names>LCC</given-names>
            </name>
            <name>
              <surname>Polanczyk</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Biolo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nascimento</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Malta</surname>
              <given-names>DC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cardiovascular Statistics - Brazil 2020</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2020</year>
          <month>09</month>
          <volume>115</volume>
          <issue>3</issue>
          <fpage>308</fpage>
          <lpage>439</lpage>
          <pub-id pub-id-type="doi">10.36660/abc20200812</pub-id>
        </element-citation>
        <mixed-citation>2 Oliveira GMM, Brant LCC, Polanczyk CA, Biolo A, Nascimento BR, Malta DC, et al. Cardiovascular Statistics - Brazil 2020. Arq Bras Cardiol. 2020 Sep;115(3):308-439. Doi: 10.36660/abc20200812.</mixed-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siqueira</surname>
              <given-names>ADE</given-names>
            </name>
            <name>
              <surname>de Siqueira</surname>
              <given-names>AG</given-names>
              <suffix>Filho</suffix>
            </name>
            <name>
              <surname>Land</surname>
              <given-names>MGP</given-names>
            </name>
          </person-group>
          <article-title>An&#225;lise do Impacto Econ&#244;mico das Doen&#231;as Cardiovasculares nos &#250;ltimos Cinco anoso no Brasil</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2017</year>
          <volume>109</volume>
          <issue>1</issue>
          <fpage>39</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="doi">10.5935/abc.20170068</pub-id>
        </element-citation>
        <mixed-citation>3 Siqueira ADE, de Siqueira-Filho AG, Land MGP. An&#225;lise do Impacto Econ&#244;mico das Doen&#231;as Cardiovasculares nos &#250;ltimos Cinco anoso no Brasil. Arq Bras Cardiol. 2017;109(1):39-46.doi:10.5935/abc.20170068.</mixed-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pr&#233;coma</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>GMM</given-names>
            </name>
            <name>
              <surname>Sim&#227;o</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Dutra</surname>
              <given-names>OP</given-names>
            </name>
            <name>
              <surname>Coelho</surname>
              <given-names>OR</given-names>
            </name>
            <name>
              <surname>Izar</surname>
              <given-names>MCO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Atualiza&#231;&#227;o da Diretriz de Preven&#231;&#227;o Cardiovascular da Sociedade Brasileira de Cardiologia &#8211; 2019</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2019</year>
          <volume>113</volume>
          <issue>4</issue>
          <fpage>787</fpage>
          <lpage>891</lpage>
          <pub-id pub-id-type="doi">10.5935/abc.20190204</pub-id>
        </element-citation>
        <mixed-citation>4 Pr&#233;coma DB, Oliveira GMM, Sim&#227;o AF, Dutra OP, Coelho OR, Izar MCO, et al. Atualiza&#231;&#227;o da Diretriz de Preven&#231;&#227;o Cardiovascular da Sociedade Brasileira de Cardiologia &#8211; 2019. Arq Bras Cardiol. 2019; 113(4):787-891. Doi:10.5935/abc.20190204.</mixed-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wakabayashi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Daimon</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Comparison of discrimination for cardio-metabolic risk by different cut-off values of the ratio of triglycerides to HDL cholesterol</article-title>
          <source>Lipids Health Dis</source>
          <year>2019</year>
          <month>07</month>
          <day>27</day>
          <volume>18</volume>
          <issue>1</issue>
          <fpage>156</fpage>
          <lpage>156</lpage>
          <pub-id pub-id-type="doi">10.1186/s2944-019-1098-0</pub-id>
        </element-citation>
        <mixed-citation>5 Wakabayashi I, Daimon T. Comparison of discrimination for cardio-metabolic risk by different cut-off values of the ratio of triglycerides to HDL cholesterol. Lipids Health Dis. 2019 Jul 27;18(1):156. Doi:10.1186/s2944-019-1098-0.</mixed-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moriyama</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>The Association between the Triglyceride to High-density Lipoprotein Cholesterol Ratio and Low-density Lipoprotein Subclasses</article-title>
          <source>Intern Med</source>
          <year>2020</year>
          <month>11</month>
          <day>01</day>
          <volume>59</volume>
          <issue>21</issue>
          <fpage>2661</fpage>
          <lpage>2669</lpage>
          <pub-id pub-id-type="doi">10.2169/internalmedicine.4954</pub-id>
        </element-citation>
        <mixed-citation>6 Moriyama K. The Association between the Triglyceride to High-density Lipoprotein Cholesterol Ratio and Low-density Lipoprotein Subclasses. Intern Med. 2020 Nov 1;59(21):2661-9. D&#243;i:10.2169/internalmedicine.4954.</mixed-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gaziano</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Hennekens</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>O'Donnell</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Breslow</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Buring</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction</article-title>
          <source>Circulation</source>
          <year>1997</year>
          <month>10</month>
          <day>21</day>
          <volume>96</volume>
          <issue>8</issue>
          <fpage>2520</fpage>
          <lpage>2525</lpage>
          <pub-id pub-id-type="doi">10.1161/01.cir.96.8.2520</pub-id>
        </element-citation>
        <mixed-citation>7 Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 1997 Oct 21;96(8):2520-5. Doi:10.1161/01.cir.96.8.2520.</mixed-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rigdon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Association of triglyceride to HDL cholesterol ratio with cardiometabolic outcomes</article-title>
          <source>J Investig Med</source>
          <year>2019</year>
          <month>03</month>
          <volume>67</volume>
          <issue>3</issue>
          <fpage>663</fpage>
          <lpage>668</lpage>
          <pub-id pub-id-type="doi">10.1136/jim-2018-000869</pub-id>
        </element-citation>
        <mixed-citation>8 Yang M, Rigdon J, Tsai SA. Association of triglyceride to HDL cholesterol ratio with cardiometabolic outcomes. J Investig Med. 2019 Mar;67(3):663-8.doi: 10.1136/jim-2018-000869.</mixed-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nie</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hou</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>High TG/HDL ratio suggests a higher risk of metabolic syndrome among an elderly Chinese population: a cross-sectional study</article-title>
          <source>BMJ Open</source>
          <year>2021</year>
          <month>03</month>
          <day>22</day>
          <volume>11</volume>
          <issue>3</issue>
          <elocation-id>e041519</elocation-id>
          <pub-id pub-id-type="doi">10.1136/bmjopen-2020-041519</pub-id>
        </element-citation>
        <mixed-citation>9 Nie G, Hou S, Zhang M, Peng W. High TG/HDL ratio suggests a higher risk of metabolic syndrome among an elderly Chinese population: a cross-sectional study. BMJ Open. 2021 Mar 22;11(3):e041519. doi: 10.1136/bmjopen-2020-041519.</mixed-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murgu&#237;a-Romero</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jim&#233;nez-Flores</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Sigrist-Flores</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Espinoza-Camacho</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Jim&#233;nez-Morales</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pi&#241;a</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>M&#233;ndez-Cruz</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Villalobos-Molina</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Reaven</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Plasma triglyceride/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults</article-title>
          <source>J Lipid Res</source>
          <year>2013</year>
          <month>10</month>
          <volume>54</volume>
          <issue>10</issue>
          <fpage>2795</fpage>
          <lpage>2799</lpage>
        </element-citation>
        <mixed-citation>10 Murgu&#237;a-Romero M, Jim&#233;nez-Flores JR, Sigrist-Flores SC, Espinoza-Camacho MA, Jim&#233;nez-Morales M, Pi&#241;a E, M&#233;ndez-Cruz AR, Villalobos-Molina R, Reaven GM. Plasma triglyceride/HDL-cholesterol ratio, insulin resistance, and cardiometabolic risk in young adults. J Lipid Res. 2013 Oct;54(10):2795-9.</mixed-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>da Silva</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Cotta</surname>
              <given-names>RMM</given-names>
            </name>
            <name>
              <surname>Mendon&#231;a</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>de Oliveira</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Cardoso</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Colodette</surname>
              <given-names>RM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Optimal Cutoff of the TG/HDL-c ratio for Cardiovascular Risk in Hypertensive and Diabetic Patients Monitored by Primary Health Care in a city in Minas Gerais</article-title>
          <source>Int J Cardiovasc Sci</source>
          <year>2021</year>
          <volume>34</volume>
          <issue>5</issue>
          <supplement>Supl.1</supplement>
          <fpage>55</fpage>
          <lpage>65</lpage>
        </element-citation>
        <mixed-citation>11 da Silva EF, Cotta RMM, Mendon&#231;a ET, de Oliveira DM, Cardoso SA, Colodette RM, et al. Optimal Cutoff of the TG/HDL-c ratio for Cardiovascular Risk in Hypertensive and Diabetic Patients Monitored by Primary Health Care in a city in Minas Gerais. Int J Cardiovasc Sci. 2021; 34(5Supl.1):55-65.</mixed-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salazar</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Carbajal</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Espeche</surname>
              <given-names>WG</given-names>
            </name>
            <name>
              <surname>Leiva Sisnieguez</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Balb&#237;n</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Dulbecco</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Aizpur&#250;a</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marillet</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Reaven</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women</article-title>
          <source>Am J Cardiol</source>
          <year>2012</year>
          <month>06</month>
          <day>15</day>
          <volume>109</volume>
          <issue>12</issue>
          <fpage>1749</fpage>
          <lpage>1753</lpage>
          <pub-id pub-id-type="doi">10.11136/bmjopen-2020-041519</pub-id>
        </element-citation>
        <mixed-citation>12 Salazar MR, Carbajal HA, Espeche WG, Leiva Sisnieguez CE, Balb&#237;n E, Dulbecco CA, Aizpur&#250;a M, Marillet AG, Reaven GM. Relation among the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardiol. 2012 Jun 15;109(12):1749-53. Doi:10.11136/bmjopen-2020-041519.</mixed-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gharipour</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sadeghi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dianatkhah</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nezafati</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Talaie</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Oveisgharan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Golshahi</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Comparison between European and Iranian cutoff points of triglyceride/high-density lipoprotein cholesterol concentrations in predicting cardiovascular disease outcomes</article-title>
          <source>J Clin Lipidol</source>
          <year>2016</year>
          <season>Jan-Feb</season>
          <volume>10</volume>
          <issue>1</issue>
          <fpage>143</fpage>
          <lpage>149</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jacl.2015.10.008</pub-id>
        </element-citation>
        <mixed-citation>13 Gharipour M, Sadeghi M, Dianatkhah M, Nezafati P, Talaie M, Oveisgharan S, Golshahi J. Comparison between European and Iranian cutoff points of triglyceride/high-density lipoprotein cholesterol concentrations in predicting cardiovascular disease outcomes. J Clin Lipidol. 2016 Jan-Feb;10(1):143-9. Doi:10.1016/j.jacl.2015.10.008.</mixed-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cordero</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Laclaustra</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Le&#243;n</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Casasnovas</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Grima</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Luengo</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MESYAS Registry Investigators. Comparison of serum lipid values in subjects with and without the metabolic syndrome</article-title>
          <source>Am J Cardiol</source>
          <year>2008</year>
          <month>08</month>
          <day>15</day>
          <volume>102</volume>
          <issue>4</issue>
          <fpage>424</fpage>
          <lpage>428</lpage>
          <pub-id pub-id-type="doi">10.1016/j.amjcard.2008.03.079</pub-id>
        </element-citation>
        <mixed-citation>14 Cordero A, Laclaustra M, Le&#243;n M, Casasnovas JA, Grima A, Luengo E,et al. MESYAS Registry Investigators. Comparison of serum lipid values in subjects with and without the metabolic syndrome. Am J Cardiol. 2008 Aug 15;102(4):424-8. Doi:10.1016/j.amjcard.2008.03.079.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
